CALGARY, AB, Sept. 29, 2026 /PRNewswire/ -- Providence Therapeutics Holdings, Inc. is pleased to announce formation of its initial Clinical Advisory Board. This advisory group will help steer Providence's therapeutic mRNA cancer vaccine programs, including the Company's personalized vaccine program for pediatric brain cancer patients as well as the...
Compelling industrial AI use cases, strong execution and AI-driven demand fuel global growth LONDON, July 23, 2025 /PRNewswire/ -- IFS, the leading provider...
Global events, 20th anniversary screenings, and digital surprises await… LONDON, July 23, 2025 /PRNewswire/ -- Wizards, witches and Muggles - wands at the ready! The countdown...
TOKYO, July 23, 2025 /PRNewswire/ -- The 2025 Zhejiang-Japan Tourism Exchange Seminar, hosted by the Zhejiang Provincial Department of Culture, Radio, Television and Tourism, was...